IL10 and colitis: In contrast, as noted above, Chassaing et al. (2015) and Viennois et al. (2018) reported roughly similar degrees of colitis with P80 and CMC (1%) in IL10−/− C57BL/6 mice and SPF C57BL/6 mice treated with DSS and azoxymethane, respectively [11,14].